Skip to main content
Isabel Arrillaga-Romany, MD, Neurology, Boston, MA

IsabelCArrillaga-RomanyMD

Neurology Boston, MA

Neurooncology

Associate Clinical Director, Neuro-Oncology, MGH Cancer Center.

Dr. Arrillaga-Romany is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Arrillaga-Romany's full profile

Already have an account?

  • Office

    101 Nicolls Rd
    Boston, MA 11794
    Phone+1 617-726-2862

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2009 - 2012
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 2008 - 2009
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 2008
  • Cornell University
    Cornell UniversityB.A., Psychology, 1999

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2012 - 2025
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Resident Scholarship to the AAN Annual Meeting American Academy of Neurology, 2012
  • David L. Kadson Award Tufts University School of Medicine, 2008
  • Obstetrics and Gynecology Student of the Year Baystate Medical Center, Tufts University School of Medicine, 2007
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Antiangiogenic Therapies for Glioblastoma  
    Arrillaga-Romany I, Norden A, CNS Oncology, 1/1/2014
  • Neurologic complications of cancer drug therapies  
    Lee EQ, Arrillaga-Romany I, Wen PY, Continuum (Minneapolis Minn), 1/1/2012

Books/Book Chapters

Abstracts/Posters

  • Newly Diagnosed Single Brain Mass - Implementation and performance of a hospital-wide management pathway.
    Isabel Arrillaga-Romany, Aneesh Singhal, Susann Jarhult, Corey Gill3, Aurelie Cordier, Benjamin White2, SooAe Jones, Michelle Pisapia, Daniel Cahill, William Curry, Jo..., Neurology; Annual Meeting of American Academy of Neurology, Washington, DC, 1/1/2015
  • Structural Brain Changes in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma.
    Isabel Arrillaga-Romany, Kourosh Jafari-Khouzani, Yi-Bin Chen, Bruce Rosen, Tracy Batchelor, and Jorg Dietrich, Neurology; Annual Meeting of American Academy of Neurology, Washington, DC, 1/1/2015
  • Eribulin induced neuropathy in a patient with previously undiagnosed Charcot-Marie-Tooth (CMT) disease.
    Arrillaga-Romany I, Ruddy KJ, Greenberg SA, Nayak L, Society for Neuro-Oncology, San Francisco, CA, 1/21/2013
  • Join now to see all

Lectures

  • Single agent ONC201 in adult recurrent H3 K27M-mutant glioma. 
    2019 ASCO Annual Meeting - 6/1/2019
  • What's on the Horizon for Newly Diagnosed Glioblastoma 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Update on Central Nervous System Tumors 
    Harvard Medical School, Boston, MA - 1/1/2014
  • Join now to see all

Other

  • The Pharmacology of Corticotropin-releasing Factor (CRF): Effects on Sensorimotor Gating in the Rat. (Thesis) 
    Arrillaga-Romany, I, Boston: ProQuest
    1/1/2006

Press Mentions

  • Chimerix (CMRX) Announces Positive ONC201 Data in Recurrent H3 K27M-Mutant Diffuse Midline Glioma to Be Presented at the Society for Neuro-Oncology Annual Meeting
    Chimerix (CMRX) Announces Positive ONC201 Data in Recurrent H3 K27M-Mutant Diffuse Midline Glioma to Be Presented at the Society for Neuro-Oncology Annual MeetingNovember 19th, 2021
  • Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-Mutant Glioma
    Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-Mutant GliomaNovember 4th, 2021
  • Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published
    Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma PublishedDecember 10th, 2019
  • Join now to see all